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.2012.08.Abstract Background: Diabetes mellitus is the most common endocrine disorder encountered
during anesthesia. Experimental researches showed that the functional l opioid receptors in the
dorsal horn of spinal cord in diabetics are either reduced or impaired in their function. This pro-
spective study was postulated to differentiate between the effects of either opioid like fentanyl ver-
sus nonopioid like dexmedetomidine agents added to spinal bupivacaine in diabetic patients.
Methods: Sixty diabetic patients of either sex were submitted for elective lower limb orthopedic sur-
gery. Patients were randomly allocated into three equal groups (each group 20 patient): bupivacaine
group in which patients received 2.5 ml of hyperbaric bupivacaine 0.5% plus 0.5 mL of normal sal-
ine, bupivacaine–fentanyl group in which patients received 2.5 ml of hyperbaric bupivacaine 0.5%
plus 25 lg fentanyl in 0.5 mL of normal saline and bupivacaine–dexmedetomidine group in which
patients received 2.5 ml of hyperbaric bupivacaine 0.5%, plus 10 lg dexmedetomidine in 0.5 mL
of normal saline. Duration and quality of sensory and motor block were assessed.
Results: The duration of sensory and motor block as well as duration of effective analgesia was signiﬁ-
cantly longer in the bupivacaine–dexmedetomidine group as compared with both bupivacaine–fentanyl
and control bupivacaine groups.
Conclusion: Addition of intrathecal dexmedetomidine to heavy bupivacaine 0.5% was more advanta-
geous than fentanyl with special regard to its analgesic properties in diabetic surgical patients.
ª 2012 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
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The prevalence of diabetes mellitus in both adults and children
has been steadily rising throughout the world for the past
20–30 years. Recent changes in diagnostic criteria, if widely
adopted, will probably also lead to more patients being classi-
ﬁed as having diabetes. Diabetic patients undergoing surgery
with neural blockade will usually resume oral intake earlier
than after general anesthesia, which confers a beneﬁt in the
diabetic surgical patients [1].osting by Elsevier B.V. Open access under CC BY-NC-ND license.
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functional mu opioid receptors in the dorsal horn of spinal
cord in diabetics are either reduced or impaired in their func-
tion. This may constitute one of the mechanisms underlying
the reduced spinal analgesic effect of l opioid in diabetic neu-
ropathic pain.
The quality of the spinal anesthesia has been reported to be
improved by the addition of opioids (such as morphine, fenta-
nyl and sufentanil) and other drugs (such as dexmedetomidine,
clonidine, magnesium sulfate (Mg), neostigmine, ketamine,
and midazolam). Alpha (a)-2-adrenergic receptor (AR) agonist
drugs, are approved to have sedative, analgesic, perioperative
sympatholytic, anesthetic-sparing, and hemodynamic-stabiliz-
ing properties [3]. Dexmedetomidine, a highly selective Alpha
(a)-2 (AR) agonist drug, when compared with clonidine, the
afﬁnity of the former to a2 receptors has been reported to be
10-times more than the latter. Kalso et al. [4] and Post et al.
[5] reported a 1:10 dose ratio between intrathecal dexmedetom-
idine and clonidine in animals. Evidence indicates that neurax-
ial administration of dexmedetomidine produces spinal
analgesia as efﬁciently as clonidine [6].
Based on the previous notion of reduction of l opioid
receptors in diabetic patients, we assumed that intrathecal
dexmedetomidine adjuvant could be more advantageous than
any intrathecal opioid addition for diabetic surgical patients.
So, this study was designed to compare the analgesic proper-
ties of intrathecal dexmedetomidine versus fentanyl added to
hyperbaric bupivacine 0.5% in diabetic patients subjected to
lower limb orthopedic surgery.
2. Patients and methods
This double-blinded randomized study was carried out on 60
diabetic patients, with long standing diabetes more than
5 years of either sex and aged more than 50 years submitted
for orthopedic lower limb surgery at Mansoura University
Hospitals. The exclusion criteria included patient refusal, pa-
tients with major cardiac, respiratory, renal, hepatic disorders
or uncontrolled diabetes mellitus, history of chronic use of
analgesic medication or hypersensitivity to drugs under inves-
tigation, any contraindication to regional anesthesia, namely;
patients with coagulopathy infection at puncture site, back-
ache, spine deformity or prior surgery, neuromuscular disor-
ders or psychic disturbances. The protocol was approved by
the responsible authorities and a written consent was secured
from all patients.
2.1. Preoperative management
All patients were assessed clinically before surgery including
full history, thorough clinical examination and laboratory
investigations (fasting and random blood sugar, blood pic-
ture, liver functions (serum albumin, prothrombin, bilirubin,
SGOT and SGPT) and kidney function (serum creatinine).
All patients were kept on insulin sliding scale and received
premedication with 5 mg diazepam orally at the night before
surgery.
On arrival to the operating suite, the patients were moni-
tored by a three leads ECG, noninvasive blood pressure and
pulse oximetry. Basal readings of heart rate (HR) mean arte-
rial blood pressure (MBP), arterial oxygen saturation (Sp02)were recorded. Intravenous access was established and each
patient was preloaded with 1000 ml of normal saline (0.9%).
The patients were randomly allocated into three equal
groups according to predetermined randomization code to
(n= 20 for each):
1. Control group (group-B): patients were given 2.5 ml of
hyperbaric bupivacaine 0.5%., plus 0.5 mL of normal
saline.
2. Bupivacaine fentanvl group: (group-BF): patients were
given 2.5 ml of hyperbaric bupivacaine 0.5%, plus
25 lg fentanyl in 0.5 mL of normal saline.
3. Bupivacaine dexmedetomidine group (group-BD):
patients were given 2.5 ml of hyperbaric bupivacaine
0.5%, plus 10 lg dexmedetomidine in 0.5 mL of nor-
mal saline.2.2. Anesthetic management
Under strict aseptic technique, subarachanoid block was per-
formed in the sitting position using 22 G spinal needle at the
L3–L4 interspace. The studied solution was slowly injected
over 10 s then the patient was turned supine. The study was
carried out in a double-blind fashion where, the attending
anesthetist was not aware of the content of injected solution
and not involved in the patient assessment. The time at which
the injection was completed was considered the zero time of
the study and all the times were recorded from this time (ex-
cept times of sensory regression from the maximal level). Mon-
itoring and assessment were carried out by a another
investigator blinded to the studied solution.
Intraoperative monitoring of heart rate, mean arterial
blood pressure and oxygen saturation were recorded 5 min
from the zero time then every 15 min. Any decrease in heart
rate below 60 beat per minute (bpm) was treated with intrave-
nous atropine (0.4 mg) according to response. Decrease in
mean blood pressure below 20% of the basal reading or below
70 mmHg was treated by ﬂuid bolus and/or 5 mg increments of
intravenous ephedrine. Any episodes of bradycardia, hypoten-
sion or desaturation were recorded. Sensory block assessment
was done by pin brick every 2 min till the maximal block level
was reached, then every 5 min. Degree of motor block was as-
sessed using a six points modiﬁed Bromage scale [7]:
1. Complete motor block.
2. Almost complete blockade, the patient was able to move
feet only.
3. Partial motor blockade, the patient was able to move the
knee.
4. Detectable weakness of hip ﬂexion, the patient was able to
raise the leg but was unable to keep it raised.
5. No detectable weakness of hip ﬂexion.
6. No weakness at all.
The assessment of motor block was performed at 5, 10,
15 min of the intrathecal injection and then every 15 min after
surgery until recovery of motor blockade were detected. Post
operative analgesia was assessed by using a visual analogue
scale (VAS/from 0 to 10 (0 = no pain at all, 10 maximum in
imaginable pain)).
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blood pressure and peripheral oxygen saturation were re-
corded in post anesthetic care unit (PACU) every 1 h till com-
plete recovery from anesthesia. Rescue analgesic medication
was done with the use of intramuscular diclofenac 75 mg when
VAS > 3 and the total analgesic requirements in the ﬁrst 24 h
after surgery were recorded. Duration of effective analgesia
was taken from the time of intrathecal drug administration
to the ﬁrst supplementation with rescue analgesic. Patients
who experienced pruritus, nausea, vomiting and urine reten-
tion were recorded.3. Statistical analysis
The statistical analysis of data was done by using excel pro-
gram and SPSS program (statistical package for social science;
SPSS Inc, Chicago, IL). Continuous variables were tested for
normal distribution by the Kolmogorov–Smirnov test. Data
was expressed as either mean and standard deviation or num-
bers and percentages. One way ANOVA was used to compare
more than two groups followed by post hoc LSD (least signif-
icant difference) test if subtraction between two means gives
PLSD this means signiﬁcant difference between the two
means. Chi square test was used for qualitative data. Kruskal
Wallis test was done to test signiﬁcance difference for nonpara-
metric values followed by Mann–Whitney test was used to test
signiﬁcance difference between two groups. P is considered sig-
niﬁcant if <0.05.4. Results
The three studied groups were comparable as regard age, sex,
height, and weight (Table 1). There was no signiﬁcant differ-
ence in heart rate, mean arterial blood pressure and arterial
oxygen saturation (SPO2) between the three studied groups
(Tables 2–4). The maximum dermatome level of sensory anes-
thesia and modiﬁed Bromage scale at 15 min after spinal anes-
thesia were comparable in the three studied groups (Tables 5
and 6).
Table 7 shows that durations of sensory blockade, as assessed
by 2 segment regression and time to regression to S2 segment,
were signiﬁcantly longer in the bupivacaine–dexmedetomidine
group as compared with both bupivacaine–fentanyl and control
bupivacaine groups. Also, the table shows the duration ofmotor
blockade (the time from intrathecal drug administration until no
motor weakness could be detected means modiﬁed bromage
scale = 6), was prolonged in bupivacaine–dexmedetomidine
group as compared with both bupivacaine–fentanyl and control
bupivacaine groups. In addition, there was a signiﬁcant prolon-Table 1 Demographic data of studied groups.
Group-B (n= 20)
Age (years) 64 ± 4
Sex (M/F) 10/10
Height (cm) 175 ± 8
Weight (kg) 75 ± 9
Group-B (bupivacaine group), group-BF (bupivacaine–Fentanyl grou
mean ± SD or patients number. No signiﬁcant differences between grougation in the duration of effective analgesic time (the time of
intrathecal drug administration to the ﬁrst supplementation
with rescue analgesics) in BD group when compared with both
BF and B groups. Also, the total analgesic requirement was sig-
niﬁcantly decreased in BF group when compared with control
group.
Visual analogue score was statistically signiﬁcant lower in
BD group than B group at 1 h, 2 h, and 3 h postoperatively.
Also VAS signiﬁcantly lowers in BD group when compared
with BF group at 1 h, 2 h, 3 h postoperatively (Table 8).
In the present study, the incidence of bradycardia, hypoten-
sion, nausea,vomiting, pruritus and urine retention was not
statistically signiﬁcant among the three groups. We did not ob-
serve any incidence of respiratory depression in the studied
groups (Table 9).
5. Discussion
The results of this study demonstrated that adding 10 lg dex-
medetomidine to spinal 12.5 mg (2.5 ml) of hyperbaric bupiv-
acaine 0.5% signiﬁcantly prolonged sensory and motor block
when compared with intrathecal 25 lg fentanyl in diabetic pa-
tients subjected to lower limb orthopedic surgery.
The situation in diabetic patients may be different than
nondiabetics. It was shown that the analgesic potency of mor-
phine and fentanyl are reduced in diabetic animals and pa-
tients [8]. Chen et al. [2] observed that functional l opioid
receptors in the spinal cord was impaired in diabetes and also
noticed the reduced analgesic action of spinally administered l
opioid agonists in diabetic neuropathic pain.
Addition of intrathecal fentanyl to spinal anesthesia has
been evaluated by several investigators on non-diabetic pa-
tients. While, Ben-David and his associates [9] found that
10 lg fentanyl added to bupivacaine would intensify the sen-
sory blockade without prolonged motor recovery, Kuusiniemi
et al. [10] suggested that addition of 25 lg fentanyl to bupiva-
caine provided good sensory level of analgesia together with
prolonged motor blockade.
In our study, the duration of sensory and motor blockade
were signiﬁcantly longer in the bupivacaine–dexmedetomidine
group as compared with both bupivacaine–fentanyl and con-
trol bupivacaine groups. The analgesic effects of intrathecal
dexmedetomidine are mediated by the hyperpolarization of
noradrenergic neurons, which suppresses neuronal ﬁring in
the locus ceruleus along with inhibition of norepinephrine re-
lease and activity in the descending medullospinal noradrener-
gic pathway, secondary to activation of central a2-ARs [6].
The suppression of activity in the descending noradrenergic
pathway, which modulates nociceptive neurotransmission, ter-
minates propagation of pain signals leading to analgesia [11].Group-BF (n= 20) Group-BD (n= 20)
70 ± 5 71 ± 9
10/10 11/9
173 ± 7 172 ± 8
74 ± 11 73 ± 12
p), group-BD (bupivacaine–dexmedetomidine group). Values are
ps (P> 0.05%).
Table 2 Heart rate changes (bpm) in studied groups.
Group-B (n= 20) Group-BF (n= 20) Group-BD (n= 20)
Intra operative
Basal 91 ± 16 85 ± 22 88 ± 14
5min 93 ± 17 96 ± 24 93 ± 14
15 min 89 ± 16 90 ± 20 86 ± 12
30 min 88 ± 17 91 ± 20 87 ± 17
60 min 86 ± 14 90 ± 15 86 ± 17
90 min 85 ± 16 92 ± 14 86 ± 12
120 min 89 ± 12 91 ± 15 88 ± 8
Post operative
1 h 85 ± 13 84 ± 10 79 ± 9
2 h 86 ± 14 82 ± 9 78 ± 8
Group B (bupivacaine group), group-BF (bupivacaine–fentanyl group), group-BD (bupivacaine–dexmedetomidine group). Values are
mean ± SD. No signiﬁcant differences between groups (P> 0.05%).
Table 3 Mean arterial blood pressure changes (mmHg) in studied groups.
Group-B (n= 20) Group-BF (n= 20) Group-BD (n = 20)
Intra operative
Basal 96 ± 10 100 ± 9.6 99 ± 13
5 min 90 ± 17 93 ± 17 91 ± 15
15 min 84 ± 14 84 ± 13 83 ± 12
30 min 84 ± 13 85 ± 14 81 ± 14
60 min 83 ± 12 83 ± 13 81 ± 12
90 min 87 ± 12 84 ± 12 83 ± 17
120 min 85 ± 12 85 ± 14 83 ± 15
Post operative
1 h 82 ± 13 86 ± 12 84 ± 11
2 h 89 ± 15 89 ± 12 86 ± 9
Group B (bupivacaine group), group-BF (bupivacaine–Fentanyl group), group-BD (bupivacaine–dexmedetomidine group). Values are
mean ± SD. No signiﬁcant differences between groups (P> 0.05%).
Table 4 Arterial oxygen saturation (SP02 %) changes in the studied groups.
Group-B (n= 20) Group-B F (n= 20) Group-BD (n= 20)
Intra operative
Basal 98 ± 2 98 ± 2 98 ± 2
5 min 98 ± 2 98 ± 2 98 ± 2
15 m in 99 ± 1 99 ± 1 98 ± 2
30 min 99 ± 1 99 ± 1 99 ± 1
60 min 99 ± 1 98 ± 2 99 ± 1
90 min 99 ± 1 99 ± 1 99 ± 1
120 min 98 ± 1 99 ± 1 98 ± 2
End 98 ± 2 98 ± 1 99 ± 1
Post operative
1 h 98 ± 1 99 ± 1 98 ± 1
2 h 98 ± 1 99 ± 1 99 ± 1
Group B (bupivacaine group), group-BF (bupivacaine–fentanyl group), group-BD (bupivacaine–dexmedetomidine group). Values are
mean ± SD. No signiﬁcant differences between groups (P> 0.05%).
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rons of superﬁcial dorsal horn especially lamina II, directly
reduces pain transmission by reducing the release of pro-
nociceptive transmitter, substance P and glutamate from
primary afferent terminals and by hyperpolarizing spinal
inter-neurons via G-protein-mediated activation of potassium
channels [12].Our results were in agreement with another study done by
Kanazi et al. [13] who found in their study that the supplemen-
tation of bupivacaine (12 mg) spinal block with a low-dose
dexmedetomidine (3 lg) produces a signiﬁcantly shorter onset
of motor block and a signiﬁcantly longer sensory and motor
block than bupivacaine alone. Al-Mustafa et al. [14] and Al-
Ghanesm et al. [15] also, observed that the use of other doses
Table 5 Maximal sensory level obtained 15 min after spinal anesthesia.
Group-B (n= 20) Group-B F (n= 20) Group-BD (n= 20)
T8 3 (15%) 2 (10%) 3 (15%)
T9 4 (20%) 4 (20%) 4 (20%)
T10 6 (30%) 7 (35%) 8 (40%)
T1 l 6 (30%) 6 (30%) 4 (20%)
T12 1 (5%) 1 (5%) 1 (5%)
Group B (bupivacaine group), group-BF (bupivacaine–fentanyl group), group-BD (bupivacaine–dexmedetomidine group). Values are patients
number (%). No signiﬁcant differences between groups (P> 0.05%).
Table 6 Motor block evaluated by modiﬁed Bromage scale after 15 min in the studied groups.
Score Group-B (n= 20) Group-BF (n= 20) Group-BD (n= 20)
1 1 (5%) 1 (5%) 1 (5%)
2 15 (75%) 16 (80%) 16 (80%)
3 4 (20%) 3 (15%) 3 (15%)
4 0 (0%) 0 (0%) 0 (0%)
Group B (bupivacaine group), group-BF (bupivacaine–fentanyl group), group-BD (bupivacaine–dexmedetomidine group). Values are patients
number (%). No signiﬁcant differences between groups (P> 0.05%).
Table 7 Characteristics of sensory and motor block of the studied groups (minutes).
Group-B (n= 20) Group-BF (n= 20) Group-BD (n= 20)
Time to 2 segment regression (min) 100 ± 25 114 ± 35 150 ± 42*#
Time to regression to S2 (min) 165 ± 34 198 ± 52 300 ± 82*#
Duration of motor block (min) 130 ± 54 149 ± 62* 175 ± 75*#
Time to ﬁrst request of analgesia (min) 250 ± 57 280 ± 61* 450 ± 84*#
Group B (bupivacaine group), group-BF (bupivacaine–fentanyl group), group-BD (bupivacaine–dexmedetomidine group). Values are
mean ± SD.
* Statistically signiﬁcant difference when compared with group-B (P< 0.05%).
# Statistically signiﬁcant difference when compared with group-BF (P< 0.05%).
Table 8 Postoperative visual analogue scale (VAS) in the studied groups.
Group-B (n= 20) Group-BF (n= 20) Group-BD (n= 20)
1 H 4 (1–5) 3 (2–4) 0 (0–3)*#
2 H 3 (1–4) 3 (2–4) 1 (0–3)*#
3 H 3 (0–4) 3 (0–4) 1 (0–3)*#
4 H 2 (1–3) 2 (0–3) 2 (0–3)
5 H 2 (1–4) 2 (0–2) 2 (0–2)
Group- B (bupivacaine group), group-BF (bupivacaine–fentanyl group), group-BD (bupivacaine–dexmedetomidine group). Values are median
(range).
* Statistically signiﬁcant difference when compared with group-B (P< 0.05%).
# Statistically signiﬁcant difference when compared with group-BF (P< 0.05%).
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onset of sensory block.
The current study ﬁndings of insigniﬁcant hemodynamic
changes were consistent with that reported of Kanazi and his
associates [13]. They reported insigniﬁcant changes in blood
pressure either intraoperatively or postoperatively with the
use of 3 lg intrathecal dexemedetomidine as an adjuvant to
bupivacaine. The reasons of no associated hemodynamic
effects in our study could be attributed mainly to good preload-
ing. Furthermore; the associated sympathetic block is usually
near maximal with bupivacaine dose used for spinal anesthesia.The addition of either dexemedetomidine or fentanyl as adju-
vants does not further inﬂuence the nearmaximal action of sym-
pathetic block of bupivacaine. The our hemodynamic ﬁndings
goes parallel with that reported by Al-Ganesm and his col-
leagues [15] who did not ﬁnd a statistical intergroup signiﬁcant
difference of bradycardia and/or hypotension with intrathecal
addition of either dexemedetomidine or fentanyl. However,
their patients were no-diabetic and no other previous studies
compare intrathecal addition of fentanyl vs dexmedetomidine.
Therefore, further clinical studies are needed to validate
the efﬁcacy and safety of the optimum intrathecal dose of
Table 9 Coincident events in the studied groups.
Group-B (n= 20) Group-BF (n= 20) Group-BD (n= 20)
Bradycardia 1 (5%) 1 (5%) 2 (10%)
Hypotension 3 (15%) 3 (15%) 3 (15%)
Nausea 0 (0%) 1 (5%) 1 (5%)
Vomiting 0 (0%) 2 (10%) 0 (0%)
Pruritus 0 (0%) 1 (5%) 0 (0%)
Urine retention 0(0%) 2 (10%) 1 (5%)
Respiratory depression 0 (0%) 0 (0%) 0 (0%)
Group B (bupivacaine group), group-BF (bupivacaine–fentanyl group), group-BD (bupivacaine–dexmedetomidine group). Values are patient s
number (%). No signiﬁcant differences between groups (P> 0.05%).
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thetics for diabetic surgical patients.
Notes about some limitations of this study could be consid-
ered. First the design did not include nondiabetic patients to
test the inﬂuence of the diabetic state and the effect of neurop-
athy on sensory and motor degree of block. Secondly, the ex-
tent and duration of diabetic state as well as degree of diabetic
neuropathy were not evaluated which may inﬂuence the results
of intrathecal adjuvants during anesthesia.
In conclusion, addition of 10 lg intrathecal dexmedetomi-
dine to 2.5 ml heavy bupivacaine 0.5% was superior than addi-
tion 25 lg fentanyl with special regard to its analgesic effect,
intensity and duration of blockade in diabetic surgical patients.References
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